Patents by Inventor Ann Coric
Ann Coric has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130213851Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: August 21, 2012Publication date: August 22, 2013Applicant: CENESTRA LLC.Inventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20120172431Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: December 5, 2011Publication date: July 5, 2012Applicant: CENESTRA LLCInventors: Seth D. Feuerstein, Ann CORIC, Louis C. Sanfilippo
-
Publication number: 20110303573Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: June 27, 2011Publication date: December 15, 2011Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
-
Patent number: 8071646Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: GrantFiled: October 28, 2009Date of Patent: December 6, 2011Assignee: Cenestra LLCInventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20100130611Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: January 25, 2010Publication date: May 27, 2010Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20100112047Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: October 28, 2009Publication date: May 6, 2010Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfitippo
-
Patent number: 7652068Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: GrantFiled: December 20, 2006Date of Patent: January 26, 2010Assignee: Cenestra LLCInventors: Seth Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20080268042Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: July 9, 2008Publication date: October 30, 2008Applicant: CENESTRA LLCInventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20070141138Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: December 20, 2006Publication date: June 21, 2007Applicant: CENESTRA LLCInventors: Seth Feuerstein, Ann Coric, Louis Sanfilippo